San Donato Hospital
| Italia | España | Turquía | |
| Trasplante de médula ósea | de $95,000 | de $71,782 | de $36,000 |
| Trasplante autólogo de médula ósea | de $90,000 | de $40,000 | de $31,500 |
| Trasplante alogénico de médula ósea de un donante no emparentado | de $150,000 | de $150,000 | de $80,000 |
| Trasplante alogénico de médula ósea de un donante emparentado | de $120,000 | de $14,083 | de $65,000 |
| Terapia biológica | de $18,000 | de $15,000 | de $5,500 |
Bookimed no añade cargos extra a los precios de los tratamientos de Linfoma. Las tarifas proceden de las listas de precios oficiales de las clínicas. Pagará directamente en la clínica por su tratamiento a su llegada al país.
Bookimed está comprometido con su seguridad. Solo trabajamos con las clínicas que mantienen altos estándares internacionales en el tratamiento de Linfoma y cuentan con las licencias necesarias para atender a pacientes internacionales en todo el mundo.
Bookimed ofrece asistencia experta gratuita. Un coordinador médico personal le apoya antes, durante y después de su tratamiento, resolviendo cualquier problema. Nunca estará solo en su viaje médico de tratamiento de Linfoma.
Jefe del Departamento de Trasplante de Médula Ósea de San Raffaele, uno de los centros más grandes de Italia con más de 90 trasplantes anuales. Especialista en el tratamiento de linfomas.
Director de la Unidad de Linfoma del Instituto Científico San Raffaele – El profesor Ferreri fundó la Fundación Italiana del Linfoma, dedicada a estudios clínicos sobre el manejo del linfoma.
Jefe de Hematología y Trasplante de Médula Ósea en San Raffaele: liderando ensayos clínicos en terapia celular y génica para cánceres de la sangre.
Escrito por Anna Leonova
Escrito por Halina Shubala
Lymphoma treatment in Italy is world-class. Leading centers like San Raffaele specialize in advanced therapies. Facilities often hold Joint Commission International and IRCCS accreditations. Italian oncology centers report up to 85% survival rates for early-stage cases. Experts perform over 52,000 operations annually in top Milanese hospitals.
Bookimed Expert Insight: Italian research hospitals offer unique value by combining academic research with clinical care. Dr. Fabio Ciceri and Dr. Jacopo Peccatori focus on complex cell and gene therapies. Their unit performs 90 allogeneic transplants annually. This high volume often leads to better outcomes in rare lymphoma subtypes. Patients should prioritize Milan-based clinics for the highest concentration of specialized hematological expertise.
Patient Consensus: Patients note the medical staff are very professional and empathetic. Many travelers emphasize that the personalized care and technology match top US centers.
Advanced CAR T-cell therapy is available in Italy for lymphoma patients. Specialized centers like San Raffaele in Milan and Gemelli in Rome provide these innovative treatments. Eligibility is managed through the AIFA Registry. Patients often access these therapies for conditions like DLBCL after other treatments fail.
Bookimed Expert Insight: San Raffaele Hospital is a premier choice for complex hematology due to its high volume and research depth. Professor Fabio Ciceri and Professor Andres Jose Maria Ferreri have published over 480 scientific papers combined. This academic focus ensures patients access the latest lymphoma protocols and clinical trials not available at standard hospitals. Their success in performing the worlds first stem cell therapy for ADA-SCID highlights their expertise in genetic and cellular medicine.
Patient Consensus: Patients note that while the process can take 2 to 3 months for approval, the results are life-saving after a relapse. Those from southern regions mentioned they often relocate to northern cities like Milan or Bologna to access these specialized treatments more quickly.
Italy reports high lymphoma success rates. Hodgkin lymphoma centers achieve 92.5% survival for first-line therapies. Specialized units report 100% cure rates for low-risk Burkitt lymphoma. Italian oncologists utilize CAR T-cell therapy and allogeneic bone marrow transplants to improve outcomes for advanced cases.
Bookimed Expert Insight: Data shows Milan is the primary hub for complex lymphoma care. San Raffaele Hospital performs 90 allogeneic transplants annually. Dr. Andres Jose Maria Ferreri founded the Italian Lymphoma Foundation to standardize high success rates. Choosing research-heavy IRCCS institutions ensures access to the latest cell and gene therapy protocols.
Patient Consensus: Patients note that Italian clinics offer survival outcomes matching Nordic standards. Many find that private care provides significantly faster access to specialists than international public systems.
Top specialized lymphoma centers in Italy include San Raffaele Hospital and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan. These facilities hold IRCCS accreditation for combining research with clinical care. They offer advanced therapies such as CAR T-cell therapy and bone marrow transplants for complex hematological cases.
Bookimed Expert Insight: San Raffaele Hospital offers a unique advantage for patients with rare or resistant lymphoma. Professor Andres Ferreri, the founder of the Italian Lymphoma Foundation, leads the Lymphoma Unit there. Our data shows his department performs 90 related and unrelated allogeneic transplants every year. This high volume directly correlates with their expertise in managing complex stem cell therapies and rare immune disorders.
Patient Consensus: Patients note that traveling to northern university hospitals often speeds up treatment by months. Many specifically recommend finding specialists like those at San Raffaele who are empathetic and highly professional.
International patients can access specialized lymphoma treatment in Italy by choosing private healthcare pathways. Non-EU citizens typically require a Schengen Medical Visa and a hospital invitation. Facilities like San Raffaele in Milan provide advanced hematology care including bone marrow transplants and CAR T-cell therapy.
Bookimed Expert Insight: While the Italian public system is resident-focused, seeking care at IRCCS-accredited research hospitals like San Raffaele ensures access to clinical trials. Dr. Jacopo Peccatori at this facility performs 90 allogeneic transplants yearly. This volume-to-outcome ratio is a primary quality indicator for international patients seeking hematological stability.
Patient Consensus: Patients note it's important to book private clinics to avoid the months-long waits found in the public system. The medical staff is described as empathic, professional, and very nice in modern, well-equipped Milanese facilities.